Analysts at Nomura started coverage on shares of Bed Bath & Beyond (NASDAQ:BBBY) in a research report issued to clients and investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating and a $65.00 price target on the stock. Nomura’s target price would indicate a potential upside of 6.56% from the company’s current price….
The company on May 28 announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas (STS). CytRx Corporation (NASDAQ:CYTR) stock performance was -5.41% in last session and…
Research analysts at Maxim Group lifted their price target on shares of Stemcells Inc (NASDAQ:STEM) from $2.50 to $5.00 in a report released on Friday. The firm currently has a “buy” rating on the stock. Maxim Group’s price objective indicates a potential upside of 155.10% from the company’s current price. StemCells Inc (NASDAQ:STEM) stock performance…
CEL-SCI Corporation (NYSEMKT:CVM) announced that Geert Kersten Chief Executive Officer will be presenting at the 2014 BIO International Convention on Wednesday June 25th at 2:00 p.m. PDT. Hosted by the Biotechnology Industry Organization (BIO) this year’s global event for biotechnology will take place June 23-26 at the San Diego Convention Center in San Diego California….
DARA Biosciences Inc (NASDAQ:DARA) on May 15 announced its support for Neuropathy Awareness Week which is being observed during the week of May 12, 2014 and sponsored in the U.S. by The Neuropathy Association (www.neuropathy.org). DARA Biosciences Inc (NASDAQ:DARA) stock performance was -26.61% in last session and finished the day at $1.60. Traded volume was…
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) presented results from a global, multi-center, open-label, comparator-controlled phase II study in patients undergoing total knee replacement surgery or total knee arthroplasty (TKA). Two doses of ISIS-FXIRx (200mg, 300mg) were compared to Sanofi’s Lovenox (enoxaparin). ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock performance was 11.26% in last session and finished the day at…
